ARCHIVES

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

This article is from The Cancer Letter archive.

Vol. 34 No. 1 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

Phase III Study: Lymphoseek Superior to Vital Blue Dye

June 24, 2011

Longer Chemo Regimen Offers Better DFS For Premenopausal Breast Cancer

January 31, 2003

NCI Increases R01 Grant Payline From 12th to 15th Percentile.

June 29, 2007

Fountain Hearings Turn Up Some Responsible Criticism, some Not, Much Support for Program

June 24, 1977

FDA Hears More Criticism On Cancer Drug Endpoints; Joint Conferences On Criteria Recommended

July 28, 1989

Frederick Center Should Have Top Scientist As Director, 20% Of Budget or Basic Research

December 21, 1973